ClinConnect ClinConnect Logo
Search / Trial NCT06516562

Demographic, Clinical, Biological, Treatment Characteristics and Cardiovascular Events of Patients With Heart Failure in Vietnam: a Multicenter Prospective Observational Study

Launched by UNIVERSITY MEDICAL CENTER HO CHI MINH CITY (UMC) · Jul 17, 2024

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Patient Registry Heart Failure Prospective Observational Study Demographic Treatment Characteristics Prognosis Mace

ClinConnect Summary

This clinical trial is focused on understanding the characteristics and treatment of patients with heart failure in Vietnam. Researchers want to learn more about how patients are cared for during their hospital stay and how they continue to receive treatment and manage their health after leaving the hospital. They will collect information about patients’ health at three different times: when they are discharged, and again at 1 month, 3 months, and 12 months after leaving the hospital.

To participate in this study, individuals need to be at least 18 years old and have been diagnosed with heart failure when they were discharged from the hospital. Specifically, they should have a measurement from a heart test showing that their heart’s ability to pump blood is reduced. Patients must also be able to communicate with healthcare staff and live in Vietnam after they leave the hospital. If eligible, participants can expect to share their health information over the course of the year, which will help improve the understanding and treatment of heart failure in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 years and older
  • Diagnosed with heart failure at the time of discharge
  • Have an ejection fraction (based on imaging modalities such as echocardiography or cardiac MRI) recorded closest to the time of discharge, showing a left ventricular ejection fraction of less than 50%
  • Exclusion Criteria:
  • Patients and their relatives do not have means of communication with healthcare staff (phone, computer, messaging, etc.)
  • Patients do not reside in Vietnam after discharge

About University Medical Center Ho Chi Minh City (Umc)

University Medical Center Ho Chi Minh City (UMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, UMC focuses on enhancing patient outcomes and contributing to the medical community by exploring cutting-edge treatments and therapies. The center fosters collaboration among healthcare professionals, researchers, and industry partners, ensuring a robust framework for conducting high-quality clinical research. With a commitment to ethical standards and patient safety, UMC plays a vital role in the development of medical knowledge and the improvement of health services in Vietnam and beyond.

Locations

Ho Chi Minh City, , Vietnam

Patients applied

0 patients applied

Trial Officials

Cong Thanh Nguyen, MD, MSc

Study Chair

University Medical Center Ho Chi Minh City

Thanh Hai Nam Phan, MD, MSc

Study Chair

University Medical Center Ho Chi Minh City

Quang Binh Truong, Professor

Study Director

University of Medicine and Pharmacy at Ho Chi Minh City

Hoang Vu Vu, PhD

Principal Investigator

University of Medicine and Pharmacy at Ho Chi Minh City

Dang Duy Quang Pham, MD, MSc

Study Chair

University Medical Center Ho Chi Minh City

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported